Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Bioverativ Inc. (BIVV)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/08/2018 |
4
| Protopapas Anna (Director) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Disposed/sold 1,056 shares
@ $0
Disposed/sold 5,455 restricted stock units
@ $0
Disposed/sold 23,006 options to buy
@ $52.08, valued at
$1.2M
|
|
| 03/08/2018 |
4
| Posner Brian S (Director) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Disposed/sold 6,693 shares
@ $0
Disposed/sold 6,364 restricted stock units
@ $0
Disposed/sold 2,980 options to buy
@ $44.51, valued at
$132.6k
Disposed/sold 26,818 options to buy
@ $44.51, valued at
$1.2M
|
|
| 03/08/2018 |
4
| PAGLIA LOUIS J (Director) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Gifted 2,000 shares
@ $0
Disposed/sold 3,056 shares
@ $0
Disposed/sold 5,455 restricted stock units
@ $0
Disposed/sold 26,818 options to buy
@ $44.51, valued at
$1.2M
|
|
| 03/08/2018 |
4
| Harris Timothy J.R. (EVP, R & D) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Disposed/sold 839 shares
@ $0
Disposed/sold 11,271 restricted stock units
@ $0
Disposed/sold 40,909 restricted stock units
@ $0
Disposed/sold 34,556 options to buy
@ $56.34, valued at
$1.9M
Disposed/sold 33,759 options to buy
@ $56.34, valued at
$1.9M
|
|
| 03/08/2018 |
4
| Greene John (EVP, CFO and Treasurer) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Disposed/sold 5,951 shares
@ $0
Disposed/sold 14,230 restricted stock units
@ $0
Disposed/sold 42,727 restricted stock units
@ $0
Disposed/sold 113,230 options to buy
@ $44.51, valued at
$5M
Disposed/sold 56,615 options to buy
@ $44.51, valued at
$2.5M
|
|
| 03/08/2018 |
4
| Germano Geno J (Director) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Disposed/sold 5,455 restricted stock units
@ $0
Disposed/sold 21,729 options to buy
@ $55.04, valued at
$1.2M
|
|
| 03/08/2018 |
4
| Duvall Diantha (Chief Accounting Officer) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Disposed/sold 2,791 shares
@ $0
Disposed/sold 2,780 restricted stock units
@ $0
Disposed/sold 7,273 restricted stock units
@ $0
Disposed/sold 7,030 options to buy
@ $52.08, valued at
$366.1k
Disposed/sold 11,062 options to buy
@ $44.51, valued at
$492.4k
|
|
| 03/08/2018 |
4
| DiFabio Andrea (EVP, Chief Legal Officer) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Disposed/sold 30,600 shares
@ $0
Disposed/sold 7,489 restricted stock units
@ $0
Disposed/sold 31,818 restricted stock units
@ $0
Disposed/sold 29,797 options to buy
@ $44.51, valued at
$1.3M
Disposed/sold 59,595 options to buy
@ $44.51, valued at
$2.7M
|
|
| 03/08/2018 |
4
| DENNER ALEXANDER J (Director) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Disposed/sold 5,001 shares
@ $0
Disposed/sold 1,165,000 shares
@ $0
Disposed/sold 5,455 restricted stock units
@ $0
Disposed/sold 26,818 options to buy
@ $44.51, valued at
$1.2M
|
|
| 03/08/2018 |
4
| Cox John (CEO) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Disposed/sold 185,094 shares
@ $0
Disposed/sold 136,364 restricted stock units
@ $0
Disposed/sold 48,678 restricted stock units
@ $0
Disposed/sold 48,230 options to buy
@ $7.82, valued at
$377.2k
Disposed/sold 387,366 options to buy
@ $44.51, valued at
$17.2M
Disposed/sold 193,683 options to buy
@ $44.51, valued at
$8.6M
|
|
| 03/08/2018 |
4
| Vivaldi Coelho Rogerio (EVP, Chief Global Therapeutics) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Disposed/sold 5,758 shares
@ $0
Disposed/sold 14,230 restricted stock units
@ $0
Disposed/sold 42,727 restricted stock units
@ $0
Disposed/sold 113,230 options to buy
@ $44.51, valued at
$5M
Disposed/sold 56,615 options to buy
@ $44.51, valued at
$2.5M
|
|
| 03/08/2018 |
4
| Celona Lucia (EVP, HR & Corp Commun. Officer) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Disposed/sold 20,396 shares
@ $0
Disposed/sold 7,489 restricted stock units
@ $0
Disposed/sold 31,818 restricted stock units
@ $0
Disposed/sold 14,899 options to buy
@ $44.51, valued at
$663.2k
Disposed/sold 59,595 options to buy
@ $44.51, valued at
$2.7M
Disposed/sold 29,797 options to buy
@ $44.51, valued at
$1.3M
|
|
| 03/08/2018 |
4
| Brudnick Richard (EVP, Business Development) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Disposed/sold 22,952 shares
@ $0
Disposed/sold 7,489 restricted stock units
@ $0
Disposed/sold 31,818 restricted stock units
@ $0
Disposed/sold 14,899 options to buy
@ $44.51, valued at
$663.2k
Disposed/sold 29,797 options to buy
@ $44.51, valued at
$1.3M
Disposed/sold 59,595 options to buy
@ $44.51, valued at
$2.7M
|
|
| 03/05/2018 |
4
| Duvall Diantha (Chief Accounting Officer) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Paid exercise price by delivering 105 shares
@ $104.73, valued at
$11k
|
|
| 02/26/2018 |
4
| Duvall Diantha (Chief Accounting Officer) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Paid exercise price by delivering 168 shares
@ $104.3, valued at
$17.5k
|
|
| 02/26/2018 |
4
| Cox John (CEO) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Paid exercise price by delivering 13,973 shares
@ $104.3, valued at
$1.5M
Paid exercise price by delivering 5,794 shares
@ $104.74, valued at
$606.9k
|
|
| 02/26/2018 |
4
| Celona Lucia (EVP, HR & Corp Commun. Officer) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Paid exercise price by delivering 1,235 shares
@ $104.3, valued at
$128.8k
Paid exercise price by delivering 389 shares
@ $104.74, valued at
$40.7k
|
|
| 02/26/2018 |
4
| DiFabio Andrea (EVP, Chief Legal Officer) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Paid exercise price by delivering 2,011 shares
@ $104.3, valued at
$209.7k
Paid exercise price by delivering 917 shares
@ $104.74, valued at
$96k
|
|
| 02/26/2018 |
4
| Brudnick Richard (EVP, Business Development) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Paid exercise price by delivering 1,419 shares
@ $104.3, valued at
$148k
Paid exercise price by delivering 924 shares
@ $104.74, valued at
$96.8k
|
|
| 02/15/2018 |
4
| Greene John (EVP, CFO and Treasurer) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Paid exercise price by delivering 2,118 shares
@ $103.52, valued at
$219.3k
Exercised 7,114 restricted stock units
@ $0 |
|
| 02/15/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/15/2018 |
4
| Vivaldi Coelho Rogerio (EVP, Chief Global Therapeutics) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Paid exercise price by delivering 2,126 shares
@ $103.52, valued at
$220.1k
Exercised 7,114 restricted stock units
@ $0 |
|
| 02/15/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/15/2018 |
4
| Cox John (CEO) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Paid exercise price by delivering 10,819 shares
@ $103.52, valued at
$1.1M
Exercised 24,339 restricted stock units
@ $0 |
|
| 02/15/2018 |
4
| Celona Lucia (EVP, HR & Corp Commun. Officer) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Paid exercise price by delivering 1,141 shares
@ $103.52, valued at
$118.1k
Exercised 3,744 restricted stock units
@ $0 |
|
| 02/15/2018 |
4
| DiFabio Andrea (EVP, Chief Legal Officer) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Paid exercise price by delivering 1,136 shares
@ $103.52, valued at
$117.6k
Exercised 3,744 restricted stock units
@ $0 |
|
| 02/13/2018 |
4
| Cox John (CEO) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Paid exercise price by delivering 7,672 shares
@ $103.05, valued at
$790.6k
Exercised 18,381 options to buy
@ $9.53, valued at
$175.2k
|
|
| 02/02/2018 |
4
| Harris Timothy J.R. (EVP, R & D) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Granted 40,909 restricted stock units
@ $0 |
|
| 02/02/2018 |
4
| Greene John (EVP, CFO and Treasurer) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Granted 42,727 restricted stock units
@ $0 |
|
| 02/02/2018 |
4
| Protopapas Anna (Director) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Granted 5,455 restricted stock units
@ $0 |
|
| 02/02/2018 |
4
| Duvall Diantha (Chief Accounting Officer) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Granted 7,273 restricted stock units
@ $0 |
|
| 02/02/2018 |
4
| Celona Lucia (EVP, HR & Corp Commun. Officer) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Granted 31,818 restricted stock units
@ $0 |
|
| 02/02/2018 |
4
| DENNER ALEXANDER J (Director) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Granted 5,455 restricted stock units
@ $0 |
|
| 02/02/2018 |
4
| Posner Brian S (Director) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Granted 6,364 restricted stock units
@ $0 |
|
|
|
|